Page last updated: 2024-10-30

metformin and Sleep Apnea, Obstructive

metformin has been researched along with Sleep Apnea, Obstructive in 5 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Sleep Apnea, Obstructive: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)

Research Excerpts

ExcerptRelevanceReference
"Eighteen OSAHS patients with T2DM, who were treated with dapagliflozin and metformin, were assigned as the dapagliflozin group."2.90Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study. ( Bai, XY; Sun, Q; Tang, Y; Zhang, M; Zhou, QL; Zhou, YF, 2019)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, Y1
Sun, Q1
Bai, XY1
Zhou, YF1
Zhou, QL1
Zhang, M1
Bajuk Studen, K1
Jensterle Sever, M1
Pfeifer, M1
Lansdown, A1
Rees, DA1
Hoppin, AG1
Katz, ES1
Kaplan, LM1
Lauwers, GY1
Aylwin, S1
Al-Zaman, Y1

Reviews

3 reviews available for metformin and Sleep Apnea, Obstructive

ArticleYear
Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
    Frontiers of hormone research, 2013, Volume: 40

    Topics: Adolescent; Adult; Androstenes; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thick

2013
The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
    Clinical endocrinology, 2012, Volume: 77, Issue:6

    Topics: Animals; Continuous Positive Airway Pressure; Electroacupuncture; Female; Heart Rate; Humans; Insuli

2012
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria

2008

Trials

1 trial available for metformin and Sleep Apnea, Obstructive

ArticleYear
Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study.
    Nutrition & diabetes, 2019, 11-04, Volume: 9, Issue:1

    Topics: Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Case-Control Studies; Diabetes Mellitus,

2019

Other Studies

1 other study available for metformin and Sleep Apnea, Obstructive

ArticleYear
Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity.
    The New England journal of medicine, 2006, Oct-12, Volume: 355, Issue:15

    Topics: Acanthosis Nigricans; Adolescent; Body Mass Index; Diabetes Mellitus, Type 2; Fatty Liver; Female; G

2006